Mike Polark
Stock Analyst at Wolfe Research
(3.41)
# 870
Out of 4,832 analysts
72
Total ratings
45.65%
Success rate
5.38%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Upgrades: Outperform | $350 | $318.80 | +9.79% | 4 | May 13, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $230 → $236 | $159.58 | +47.89% | 7 | May 6, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $133 → $150 | $140.61 | +6.68% | 8 | May 2, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $22.24 | +30.40% | 1 | Mar 31, 2025 | |
| EW Edwards Lifesciences | Downgrades: Underperform | $60 | $76.17 | -21.23% | 4 | Jan 16, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $247.72 | -27.34% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $95.50 | - | 1 | Sep 10, 2024 | |
| SYK Stryker | Initiates: Outperform | $405 | $385.04 | +5.18% | 1 | Sep 10, 2024 | |
| LIVN LivaNova | Maintains: Neutral | $55 | $43.95 | +25.14% | 8 | Aug 28, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $487 → $503 | $560.59 | -10.27% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $128.99 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $125.74 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $85.79 | +41.04% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $23.09 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $12.93 | +93.35% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $154.80 | +6.59% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $102.76 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | n/a | $84.10 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $14.82 | -12.28% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $5.78 | +263.64% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $227.20 | +10.04% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.67 | +2,482.58% | 1 | Sep 2, 2020 |
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $318.80
Upside: +9.79%
Inspire Medical Systems
May 6, 2025
Maintains: Outperform
Price Target: $230 → $236
Current: $159.58
Upside: +47.89%
iRhythm Technologies
May 2, 2025
Maintains: Outperform
Price Target: $133 → $150
Current: $140.61
Upside: +6.68%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $22.24
Upside: +30.40%
Edwards Lifesciences
Jan 16, 2025
Downgrades: Underperform
Price Target: $60
Current: $76.17
Upside: -21.23%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $247.72
Upside: -27.34%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $95.50
Upside: -
Stryker
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $385.04
Upside: +5.18%
LivaNova
Aug 28, 2024
Maintains: Neutral
Price Target: $55
Current: $43.95
Upside: +25.14%
Intuitive Surgical
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $560.59
Upside: -10.27%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $128.99
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $125.74
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $85.79
Upside: +41.04%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $23.09
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $12.93
Upside: +93.35%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $154.80
Upside: +6.59%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $102.76
Upside: -
Jul 6, 2022
Initiates: Underperform
Price Target: n/a
Current: $84.10
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $14.82
Upside: -12.28%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $5.78
Upside: +263.64%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $227.20
Upside: +10.04%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.67
Upside: +2,482.58%